Acura Pharmaceuticals Inc: Acura Pharmaceuticals : New Financial Obligation Form 8 K
(marketscreener.com) Amended Loan Schedule to Secured Promissory Note dated November 10, 2022 between Acura Pharmaceuticals, Inc. and Abuse Deterrent Pharma, LLC Date Principal ...https://www.marketscreener.com/quote/stock/ACURA-PHARMACEUTICALS-INC-120789192/news/Acura-Pharmaceuticals-New-Financial-Obligation-Form-8-K-47484961/?utm_medium=RSS&utm_content=20240726
Read full article »
Acura Pharmaceuticals is engaged in the development and commercialization of abuse-deterrent products.
Read more